Funder
National Institute of Allergy and Infectious Diseases
University of North Carolina
Vaccine Research Center
Caisse des dépôts et consignations
National Cancer Institute
Reference64 articles.
1. Critical ACE2 determinants of SARS-CoV-2 and group 2B coronavirus infection and replication;Adams;mBio,2021
2. The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants;Ao;MedComm,2023
3. Comparison of COVID-19 severity in vaccinated and unvaccinated patients during the delta and Omicron wave of the pandemic in a romanian tertiary infectious diseases hospital;Briciu;Healthcare,2023
4. SARS-CoV-2 variant biology: immune escape, transmission and fitness;Carabelli;Nat. Rev. Microbiol.,2023
5. The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1, and XBB.1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties - an alarming global threat of a surge in COVID-19 cases again?;Chakraborty;Int. J. Surg.,2023
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献